Lip Cancer · Prognosis & follow-up

What is the prognosis for lip cancer?

Reviewed: 8 November 2026 By: Xiangpeng Liu, MD Topic: Lip Cancer Answer length: short, citable
Quick answer

Small, completely excised lower-lip squamous cell carcinomas have excellent control, with five-year survival commonly reported above 90%. Prognosis falls with large size, deep invasion, perineural spread, mandibular involvement, nodal metastasis and immunosuppression. Recurrence and new UV-related skin cancers are common enough that long-term skin surveillance is standard.

In detail

Published survival figures are population averages from registry data. Your own outlook depends on stage, HPV or EBV status, margins, nodal involvement, general health, smoking status during treatment and response to the first treatment.

Most recurrences occur within the first two to five years. Follow-up visits are frequent at first (every one to three months in year one) and become annual after year five, in line with NCCN survivorship guidance.

What this means in practice: this answer is part of the “Prognosis & follow-up” section of the Lip Cancer topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.

Other common questions about lip cancer

See all 14 questions in this topic →

Sources for this answer

  1. NCCN Guidelines for Patients: Head and Neck Cancers National Comprehensive Cancer Network · 2025
  2. Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022 CA: A Cancer Journal for Clinicians · 2026 · Subsite-level estimates for 185 countries; the basis of the regional atlas on this site.
  3. Trends of lip, oral cavity and oropharyngeal cancers in Australia 1982–2008 BMC Cancer · 2013 · Lip cancer was the dominant oral-region subsite in Australia; strongly UV-related.
  4. Global Cancer Observatory (GLOBOCAN 2022) International Agency for Research on Cancer / WHO · 2022 · Source of worldwide and country-level incidence and mortality estimates.
  5. Ultraviolet radiation and skin cancer (fact sheet) World Health Organization · 2024

Written and medically reviewed by Xiangpeng Liu, MD

Associate Chief Physician, ENT & Head/Neck Surgery · Chenzhou First People’s Hospital, Chenzhou, Hunan, China

Editorial policy & reviewer credentials · All sources

Need an opinion on your own case?

International patients can request a preliminary review based on pathology and imaging before travelling to China.

How the pathway works Send an enquiry

Medical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.